Status:
WITHDRAWN
Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion
Lead Sponsor:
Vital Therapies, Inc.
Conditions:
Acute Liver Failure
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
VTI-207 (NCT01452295) is designed to follow subjects, both treated and control, for five years after their completion of study participation in protocol VTI-206 (NCT00973817) to gather information rel...
Detailed Description
Vital Therapies, Inc. (VTI) is conducting clinical trial VTI-206 in which subjects with acute on chronic hepatitis (AOCH) and acute alcoholic hepatitis (AAH) are treated with the ELAD system to assess...
Eligibility Criteria
Inclusion
- Subjects participating in the VTI-206 clinical trial.
Exclusion
- Subjects not participating in the VTI-206 clinical trial.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01452295
Start Date
June 1 2010
End Date
September 1 2012
Last Update
December 4 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.